Greg Stein

Greg Stein is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Divisional Manager for the Foundational Products Team at Inizio since November 2022, where responsibilities include managing eight clinical specialists across twelve states and promoting Actemra, an IL-6 biologic for moderate to severe Rheumatoid Arthritis. Prior to this, Greg held the position of Area Sales Manager at Ashfield, part of UDG Healthcare, beginning in September 2019, focusing on promoting Vabysmo for Neovascular Age Related Macular Degeneration and Diabetic Macular Edema. Greg's prior experience includes serving as a Senior Influenza Specialist at Teva Pharmaceuticals from February 2010 to July 2019 and a Senior Sales Professional. Greg holds a Bachelor of Science in Business Administration with a focus in Marketing from Xavier University, earned in December 1990.